CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery

The short release half-life of carbon monoxide (CO) is a major obstacle to the effective therapeutic use of carbon monoxide-releasing molecule-2 (CORM-2). The potential of CORM-2-entrapped ultradeformable liposomes (CORM-2-UDLs) to enhance the release half-life of CO and alleviate skin inflammation...

Full description

Bibliographic Details
Main Authors: Gwan-Yeong Lee, Alam Zeb, Eun-Hye Kim, Beomseon Suh, Young-Jun Shin, Donghyun Kim, Kyoung-Won Kim, Yeong-Hwan Choe, Ho-Ik Choi, Cheol-Ho Lee, Omer Salman Qureshi, In-Bo Han, Sun-Young Chang, Ok-Nam Bae, Jin-Ki Kim
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383520305931
_version_ 1818591621132845056
author Gwan-Yeong Lee
Alam Zeb
Eun-Hye Kim
Beomseon Suh
Young-Jun Shin
Donghyun Kim
Kyoung-Won Kim
Yeong-Hwan Choe
Ho-Ik Choi
Cheol-Ho Lee
Omer Salman Qureshi
In-Bo Han
Sun-Young Chang
Ok-Nam Bae
Jin-Ki Kim
author_facet Gwan-Yeong Lee
Alam Zeb
Eun-Hye Kim
Beomseon Suh
Young-Jun Shin
Donghyun Kim
Kyoung-Won Kim
Yeong-Hwan Choe
Ho-Ik Choi
Cheol-Ho Lee
Omer Salman Qureshi
In-Bo Han
Sun-Young Chang
Ok-Nam Bae
Jin-Ki Kim
author_sort Gwan-Yeong Lee
collection DOAJ
description The short release half-life of carbon monoxide (CO) is a major obstacle to the effective therapeutic use of carbon monoxide-releasing molecule-2 (CORM-2). The potential of CORM-2-entrapped ultradeformable liposomes (CORM-2-UDLs) to enhance the release half-life of CO and alleviate skin inflammation was investigated in the present study. CORM-2-UDLs were prepared by using soy phosphatidylcholine to form lipid bilayers and Tween 80 as an edge activator. The deformability of CORM-2-UDLs was measured and compared with that of conventional liposomes by passing formulations through a filter device at a constant pressure. The release profile of CO from CORM-2-UDLs was evaluated by myoglobin assay. In vitro and in vivo anti-inflammatory effects of CORM-2-UDLs were assessed in lipopolysaccharide-stimulated macrophages and TPA-induced ear edema model, respectively. The deformability of the optimized CORM-2-UDLs was 2.3 times higher than conventional liposomes. CORM-2-UDLs significantly prolonged the release half-life of CO from 30 s in a CORM-2 solution to 21.6 min. CORM-2-UDLs demonstrated in vitro anti-inflammatory activity by decreasing nitrite production and pro-inflammatory cytokine levels. Furthermore, CORM-2-UDLs successfully ameliorated skin inflammation by reducing ear edema, pathological scores, neutrophil accumulation, and inflammatory cytokines expression. The results demonstrate that CORM-2-UDLs could be used as promising therapeutics against acute skin inflammation.
first_indexed 2024-12-16T10:15:21Z
format Article
id doaj.art-17892d56a06e492384130a87cc395e98
institution Directory Open Access Journal
issn 2211-3835
language English
last_indexed 2024-12-16T10:15:21Z
publishDate 2020-12-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj.art-17892d56a06e492384130a87cc395e982022-12-21T22:35:28ZengElsevierActa Pharmaceutica Sinica B2211-38352020-12-01101223622373CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO deliveryGwan-Yeong Lee0Alam Zeb1Eun-Hye Kim2Beomseon Suh3Young-Jun Shin4Donghyun Kim5Kyoung-Won Kim6Yeong-Hwan Choe7Ho-Ik Choi8Cheol-Ho Lee9Omer Salman Qureshi10In-Bo Han11Sun-Young Chang12Ok-Nam Bae13Jin-Ki Kim14College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea; Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, PakistanCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of KoreaDepartment of Pharmacy, Forman Christian College, Lahore 54600, PakistanDepartment of Neurosurgery, CHA Bundang Medical Center, School of Medicine, CHA University, Seongnam 13496, Republic of KoreaCollege of Pharmacy, Ajou University, Suwon 16499, Republic of KoreaCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea; Corresponding authors. Tel.: +82 31 4005805; fax: +82 31 4005958 (Ok-Nam Bae); Tel.: +82 31 4005808; fax: +82 31 4005958 (Jin-Ki Kim).College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea; Corresponding authors. Tel.: +82 31 4005805; fax: +82 31 4005958 (Ok-Nam Bae); Tel.: +82 31 4005808; fax: +82 31 4005958 (Jin-Ki Kim).The short release half-life of carbon monoxide (CO) is a major obstacle to the effective therapeutic use of carbon monoxide-releasing molecule-2 (CORM-2). The potential of CORM-2-entrapped ultradeformable liposomes (CORM-2-UDLs) to enhance the release half-life of CO and alleviate skin inflammation was investigated in the present study. CORM-2-UDLs were prepared by using soy phosphatidylcholine to form lipid bilayers and Tween 80 as an edge activator. The deformability of CORM-2-UDLs was measured and compared with that of conventional liposomes by passing formulations through a filter device at a constant pressure. The release profile of CO from CORM-2-UDLs was evaluated by myoglobin assay. In vitro and in vivo anti-inflammatory effects of CORM-2-UDLs were assessed in lipopolysaccharide-stimulated macrophages and TPA-induced ear edema model, respectively. The deformability of the optimized CORM-2-UDLs was 2.3 times higher than conventional liposomes. CORM-2-UDLs significantly prolonged the release half-life of CO from 30 s in a CORM-2 solution to 21.6 min. CORM-2-UDLs demonstrated in vitro anti-inflammatory activity by decreasing nitrite production and pro-inflammatory cytokine levels. Furthermore, CORM-2-UDLs successfully ameliorated skin inflammation by reducing ear edema, pathological scores, neutrophil accumulation, and inflammatory cytokines expression. The results demonstrate that CORM-2-UDLs could be used as promising therapeutics against acute skin inflammation.http://www.sciencedirect.com/science/article/pii/S2211383520305931Carbon monoxideCORM-2Anti-inflammatory effectUltradeformable liposomesSkin inflammationEar edema
spellingShingle Gwan-Yeong Lee
Alam Zeb
Eun-Hye Kim
Beomseon Suh
Young-Jun Shin
Donghyun Kim
Kyoung-Won Kim
Yeong-Hwan Choe
Ho-Ik Choi
Cheol-Ho Lee
Omer Salman Qureshi
In-Bo Han
Sun-Young Chang
Ok-Nam Bae
Jin-Ki Kim
CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery
Acta Pharmaceutica Sinica B
Carbon monoxide
CORM-2
Anti-inflammatory effect
Ultradeformable liposomes
Skin inflammation
Ear edema
title CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery
title_full CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery
title_fullStr CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery
title_full_unstemmed CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery
title_short CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery
title_sort corm 2 entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective co delivery
topic Carbon monoxide
CORM-2
Anti-inflammatory effect
Ultradeformable liposomes
Skin inflammation
Ear edema
url http://www.sciencedirect.com/science/article/pii/S2211383520305931
work_keys_str_mv AT gwanyeonglee corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT alamzeb corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT eunhyekim corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT beomseonsuh corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT youngjunshin corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT donghyunkim corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT kyoungwonkim corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT yeonghwanchoe corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT hoikchoi corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT cheolholee corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT omersalmanqureshi corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT inbohan corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT sunyoungchang corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT oknambae corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery
AT jinkikim corm2entrappedultradeformableliposomesameliorateacuteskininflammationinanearedemamodelviaeffectivecodelivery